https://thecapitolforum.com/hims-hers-health-questions-remain-about-compounding-viability/
Hims & Hers Health: Questions Remain About Compounding Viability Post Resolution of Semaglutide...
Feb 24, 2025 - The Food and Drug Administration announced on Feb. 21 that the years-long shortage of semaglutide, the active ingredient in Novo Nordisk’s blockbuster...
health questionsabout compoundinghimsremain